99 related articles for article (PubMed ID: 4016789)
1. Phase I study of vinblastine and verapamil given by concurrent iv infusion.
Benson AB; Trump DL; Koeller JM; Egorin MI; Olman EA; Witte RS; Davis TE; Tormey DC
Cancer Treat Rep; 1985; 69(7-8):795-9. PubMed ID: 4016789
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors.
Cairo MS; Siegel S; Anas N; Sender L
Cancer Res; 1989 Feb; 49(4):1063-6. PubMed ID: 2536292
[TBL] [Abstract][Full Text] [Related]
3. Phase I and pharmacokinetic study of the P-glycoprotein modulator dexniguldipine-HCL.
Nuessler V; Scheulen ME; Oberneder R; Kriegmair M; Goebel KJ; Rathgeb F; Wurst W; Zech K; Wilmanns W
Eur J Med Res; 1997 Feb; 2(2):55-61. PubMed ID: 9085015
[TBL] [Abstract][Full Text] [Related]
4. Phase I and pharmacological study of vinblastine by prolonged continuous infusion.
Ratain MJ; Vogelzang NJ
Cancer Res; 1986 Sep; 46(9):4827-30. PubMed ID: 3731129
[TBL] [Abstract][Full Text] [Related]
5. Phase I-II trial of a 5-day continuous infusion of vinblastine sulfate.
Zeffren J; Yagoda A; Kelsen D; Winn R
Anticancer Res; 1984; 4(6):411-3. PubMed ID: 6517534
[TBL] [Abstract][Full Text] [Related]
6. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
7. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
[TBL] [Abstract][Full Text] [Related]
8. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
9. Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer.
Yap HY; Blumenschein GR; Keating MJ; Hortobagyi GN; Tashima CK; Loo TL
Cancer Treat Rep; 1980; 64(2-3):279-83. PubMed ID: 7407762
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of divided-dose vinblastine in advanced malignancy.
Young JA; Westlake D; Schnetzer GW; Keller AM; Sexauer JM; Newcomer LN
Cancer Treat Rep; 1985 Jun; 69(6):607-10. PubMed ID: 4016767
[TBL] [Abstract][Full Text] [Related]
11. Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate.
Matin K; Egorin MJ; Ballesteros MF; Smith DC; Lembersky B; Day RS; Johnson CS; Trump DL
Cancer Chemother Pharmacol; 2002 Sep; 50(3):179-85. PubMed ID: 12203099
[TBL] [Abstract][Full Text] [Related]
12. A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer.
Kouroussis C; Kalbakis K; Androulakis N; Agelaki S; Vamvakas L; Malas K; Souglakos J; Vardakis N; Georgoulias V
Anticancer Res; 2004; 24(6):4217-21. PubMed ID: 15736475
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancer.
Yap HY; Blumenschein GR; Hortobagyi GN; Buzdar AU; Schell FC; Bodey GP
Am J Clin Oncol; 1982 Oct; 5(5):511-4. PubMed ID: 7180829
[TBL] [Abstract][Full Text] [Related]
14. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
15. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
[TBL] [Abstract][Full Text] [Related]
17. Concurrent phase I trials of intravenous interleukin 6 in solid tumor patients: reversible dose-limiting neurological toxicity.
Sosman JA; Aronson FR; Sznol M; Atkins MB; Dutcher JP; Weiss GR; Isaacs RE; Margolin KA; Fisher RI; Ernest ML; Mier J; Oleksowicz L; Eckhardt JR; Levitt D; Doroshow JH
Clin Cancer Res; 1997 Jan; 3(1):39-46. PubMed ID: 9815535
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial.
Stiff PJ; Bayer R; Tan S; Camarda M; Sosman J; Peace D; Kinch L; Rad N; Loutfi S
Clin Cancer Res; 1995 Dec; 1(12):1495-502. PubMed ID: 9815949
[TBL] [Abstract][Full Text] [Related]
19. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.
Berlion M; Arvelo F; Leonce S; Bourgeois Y; Rigaudy P; Bizzari JP; Poupon MF
In Vivo; 1993; 7(5):399-405. PubMed ID: 7906553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
